Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Praticien-chercheur
17 articles scientifiques publiés — formation continue solide
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
7 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
13
13 articles ont été cités au moins 13fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
788
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
68
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
16
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Hôpital Beaujon · Assistance Publique – Hôpitaux de Paris
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
2025ArticleThe Lancet Gastroenterology & Hepatology
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
2022ArticleLiver Cancer
Factors and Mechanisms Involved in Acquired Developmental Defects of Enamel: A Scoping Review
2022ArticleFrontiers in Pediatrics
Safety of sitagliptin in treatment of hepatocellular carcinoma in chronic liver disease patients
2021ArticleLiver Cancer International
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
2021ArticleJHEP Reports Innovation in Hepatology
LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?
2021ArticleEuropean Journal of Radiology
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
2019ArticleNature Immunology
Role of dipeptidyl peptidase-4 in the regulation of leucocyte trafficking in hepatocellular carcinoma
2017Thèse
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP NUP SITE BEAUJON
100 BD DU GENERAL LECLERC, 92118 CLICHY CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
JHEP reports : innovation in hepatology · 2021
Frontiers in pediatrics · 2022
BackgroundDevelopmental Defects of Enamel (DDE) is a pathology of the teeth that can greatly alter the quality of life of patients (hypersensitivity, esthetic issues, loss of function, etc.). The acquired DDE may occur as a result of a wide range of acquired etiological factors and his prevalence of this pathology may reach up to 89.9%. The main objective of this research was to identify and analyze, in current literature, the factors related to acquired DDE, in order to propose a general theory about the mechanisms involved.MethodsThe search of the primary literature was conducted until [December 31, 2021]. Our search strategy uses the Pubmed/MEDLINE database and was structured around 3 terms [“Development,” “Defect,” and “Enamel”]. To be included, references had to be primary studies, written in English. Exclusion criteria were reviews, in vitro, animal, genetic or archeology studies, and studies focused on clinical management of DDE. One hundred and twenty three articles were included in this scoping review: 4 Randomized clinical trials, 1 letter, 5 cases reports, 2 fundamentals studies, and 111 observational studies (33 Cross-sectional studies, 68 Cohort study and 10 Case-control study). The quality of evidence was assessed using the PEDro scale for clinical trials, the Newcastle-Ottawa scale for observational studies, and a published tool to assess the quality of case reports and case series.ResultsA scoping review of the literature identified 114 factors potentially involved in acquired DDE. The most frequently encountered pathologies are those causing a disorder of calcium homeostasis or a perturbation of the ARNT pathway in mother or child. The link between the ARNT pathway and metabolism deficiency in uncertain and needs to be defined. Also, the implication of this mechanism in tissue impairment is still unclear and needs to be explored.ConclusionsBy identifying and grouping the risk factors cited in the literature, this taxonomy and the hypotheses related to the mechanism allow health practitioners to adopt behaviors that limit the risk of developing aDDE and to set up a prevention of dental pathology. In addition, by reviewing the current literature, this work provides guidance for basic research, clinical studies, and literature searches.
Journal of clinical medicine · 2023
Background and aims: the side effects of immune checkpoint inhibitors (ICI) pose a problem for the clinical management of cancer patients. There is a lack of knowledge of the value of liver biopsy in patients with ICI-related drug-induced liver injury (ICI-DILI). The aim of this study was to explore the impact of liver biopsy on clinical management and response to corticosteroids, according to histological findings. Methods: We conducted a retrospective, single-center study to evaluate the biochemical, histological and clinical data of 35 patients with ICI-DILI between 2015 and 2021 in a university hospital in France. Results: Of the 35 patients with ICI-DILI (median [interquartile range] age 62 [48–73] years, 40% males) studied, 20 underwent a liver biopsy. There was no difference in the management of ICI-DILI according to liver biopsy in terms of ICI withdrawal, reduction or rechallenge. According to the histological profile, patients with toxic and granulomatous profiles had a better response to corticosteroids, while patients with cholangitic lesions had the worst response. Conclusion: In ICI-DILI, liver biopsy must not delay patient care but may be useful in identifying patients with a cholangitic profile who have a poorer response to corticosteroids.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Liver cancer · 2026 · Journal Article
Giannini EG, Pasta A, Pieri G, Labanca S, et al.
The lancet. Gastroenterology & hepatology · 2025 · Journal Article
Nault JC, Boubaya M, Wartski M, Dohan A, et al.
JHEP reports : innovation in hepatology · 2024 · Journal Article
Nault JC, Sritharan N, Verset G, Borbath I, et al.
Hepatobiliary surgery and nutrition · 2024 · Editorial
Bouattour M, Devictor J, Hollande C
Journal of clinical medicine · 2023 · Journal Article
Parlati L, Marcin K, Terris B, Vallet-Pichard A, et al.
Autoimmunity reviews · 2021 · Letter
David C, Chaigne B, Hollande C, Terris B, et al.
Clinics and research in hepatology and gastroenterology · 2021 · Journal Article
Parlati L, Hollande C, Pol S
European journal of radiology · 2021 · Journal Article
Barat M, Nguyen TTL, Hollande C, Coty JB, et al.
Medicine · 2016 · Journal Article
Hollande C, Mallet V, Darbeda S, Vallet-Pichard A, et al.
Annals of hepatology · 2023 · Journal Article
Brustia R, Bouattour M, Allaire M, Lequoy M, et al.
Liver international : official journal of the International Association for the Study of the Liver · 2022 · Journal Article
Muñoz-Martínez S, Sapena V, Forner A, Bruix J, et al.
JHEP reports : innovation in hepatology · 2021 · Journal Article
Amaddeo G, Brustia R, Allaire M, Lequoy M, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2026 · Journal Article
Campani C, Shim JH, Bouattour M, Touchefeu Y, et al.
Expert opinion on emerging drugs · 2024 · Journal Article
Stella L, Hollande C, Merabet YB, Fakhouri H, et al.
JHEP reports : innovation in hepatology · 2026 · Journal Article
Métivier C, Campani C, Allaire M, Morello R, et al.
JHEP reports : innovation in hepatology · 2026 · Journal Article
Akkus E, Hobeika C, Edeline J, Hollande C, et al.
Frontiers in pediatrics · 2022 · Journal Article
Collignon AM, Vergnes JN, Germa A, Azogui S, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2026 · Journal Article
Campani C, Shim JH, Bouattour M, Touchefeu Y, et al.